Today is part one of a two week series on challenging the status quo with the Co-Founders of Ambio Life Sciences, the world leader in integrative ibogaine therapies. 

Jonathon Dickenson, co-founder and CEO, courageously talks about his own experience with mental health, being curious in our approach to modern medicine and the groundbreaking impact of psychedelics on dealing with difficult life transitions, trauma and flow states.

Ambio’s clinics in Mexico have treated over 650 people with ibogaine in 2023 for a range of conditions ranging from addiction to combat-related traumatic brain injuries. 

Jonathan’s on a mission is to make psychedelic therapy more accessible and to change the world through its transformative power. He’s involved in botanical and biological research on plant sources, psychological research to help us understand the ibogaine experience, medical case studies and clinical work to unlock the link between ibogaine’s psychotherapeutic effects and the body.

His story is one of strength, vulnerability, courage and generosity.

Follow Jonathon and Ambio Life Sciences on Instagram. Follow The Uncharted Leader on Linkedin, Instagram and YouTube.  Book a call with Kylee and ask about The Emerging Leaders Program to ignite your passion, grow your influence and amplify the impact you have in the world.

Podcast proudly sponsored by The Performance Code